期刊文献+

含氮双膦酸盐治疗38例晚期乳腺癌骨转移的疗效及不良反应观察 被引量:1

下载PDF
导出
摘要 目的观察含氮双膦酸盐(择泰)注射液治疗乳腺癌骨转移疼痛的疗效及不良反应。方法 38例乳腺癌骨转移患者给予择泰4mg,每月一次,1个月为1周期,治疗5个周期评价疗效。结果 38例患者治疗后止痛:显效11例,占30.0%,有效19例,占50%,无效8例占20%,总有效率80.0%。38例活动能力改善情况:显效22例,占58%,有效9例,占24%,总有效率31例,占82%。不良反应:流感样症状(约9%),包括骨痛(9.1%)、发热(6.7%)、疲乏(4.1%)、寒战(2.8%)以及关节痛和肌痛(约3%)。结论择泰治疗乳腺癌骨转移引起的疼痛安全有效,值得临床推广应用。
出处 《海峡药学》 2012年第8期122-123,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献1

二级参考文献7

  • 1[1]Bunn PA, Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions[J].Clin Cancer Res, 1998, 5:1087-2000.
  • 2[2]Bonomi P. Review of taxol/carboplatin in advanced nonsmall cell lung cancer[J]. Semin Oncol, 1999, 26(2 Suppl): 55-59.
  • 3[3]Bunn PA. Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced nonsmall cell lung cancer[J]. Semin Oncol, 1999, 26(4 Suppl):25-30.
  • 4[4]Chen MC, Chiang AA, Chow JM, et al. Taxol in combination with doxorubicin or epirubicin in treating advanced non-small-cell lung cancer[J]. Proc Am Soc Oncol,1998, 17:480a.
  • 5[5]Ceresoli GL, Dell'Oro S, Passoni P, et al. Phase Ⅱ study of taxol and epirubicin as first-line treatment in patients with metastatic non-small cell lung carcinoma[J]. Cancer,2000, 89(1): 89-96.
  • 6[6]Berger T, Malayeri R, Doppelbauer A, et al. Neurological monitoring of neurotoxicity induced by taxol/cisplatin chemotherapy[J]. Eur J Cancer, 1997, 33:1393-1399.
  • 7[7]Smith IE, O'Brien MER, Norton A, et al. Duration of chemotherapy for advanced non-small cell lung cancer: a phase Ⅲ randomized trial of 3 versus 6 courses of mitomycin C, vinblastine, cisplatin(MPV)[J]. Proc Am Soc Oncol, 1998, 17:457a.

共引文献5

同被引文献14

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部